Brief: A1m Pharma Reports Positive Results From Preclinical Study In Acute Kidney Injuries

Disruptive Pharma AB (publ)

23/07/2018 07:31

A1M Pharma AB  A1M.ST :
    * A1M PHARMA REPORTS POSITIVE RESULTS FROM PRECLINICAL STUDY
IN
ACUTE KIDNEY INJURIES
    * SAYS ROSGARD™, SIGNIFICANTLY REDUCES DAMAGING EFFECTS ON
KIDNEYS
FOLLOWING EXPOSURE TO SEVERE OXIDATIVE STRESS

Source text for Eikon:  ID:nBQNb0z1dY 
Further company coverage:  A1M.ST